Artivion (AORT)
(Real Time Quote from BATS)
$25.28 USD
+0.13 (0.52%)
Updated Aug 8, 2024 01:54 PM ET
3-Hold of 5 3
C Value C Growth B Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
AORT 25.28 +0.13(0.52%)
Will AORT be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for AORT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AORT
ClearPoint Neuro, Inc. (CLPT) Reports Q2 Loss, Tops Revenue Estimates
Inogen (INGN) Reports Q2 Loss, Tops Revenue Estimates
AORT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Alphatec (ATEC) Reports Q2 Loss, Tops Revenue Estimates
Strength Seen in AxoGen (AXGN): Can Its 5.4% Jump Turn into More Strength?
Artivion, Inc. (AORT) Hit a 52 Week High, Can the Run Continue?
Other News for AORT
Artivion to Participate in Upcoming Investor Conferences
Lake Street Sticks to Their Buy Rating for Artivion (AORT)
Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2024 Financial Results
Next Century Growth Investors Q2 2024 Commentary
Artivion Amends Agreements with Endospan